Peripheral nerve abnormalities in pediatric patients with spinal muscular atrophy

被引:20
|
作者
Yonekawa, Takahiro [1 ]
Komaki, Hirofumi [1 ]
Saito, Yuko [2 ]
Sugai, Kenji [1 ]
Sasaki, Masayuki [1 ]
机构
[1] NCNP, Natl Ctr Hosp, Dept Child Neurol, Tokyo 1878551, Japan
[2] NCNP, Natl Ctr Hosp, Dept Pathol & Lab Med, Tokyo 1878551, Japan
来源
BRAIN & DEVELOPMENT | 2013年 / 35卷 / 02期
关键词
Spinal muscular atrophy; Nerve conduction study; Peripheral nerve abnormality; Sensory nerve degeneration; Wallerian degeneration; WERDNIG-HOFFMANN DISEASE; CONDUCTION-VELOCITY; MOTOR; INVOLVEMENT;
D O I
10.1016/j.braindev.2012.03.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined the specific nerve conduction deficits distinguishing spinal muscular atrophy (SMA) subtypes I and II. Five SMA I patients (age, 0.2-1.1 years) and 10 SMA II patients (age, 1.0-2.8 years) were examined. Patients were compared to age-matched controls for motor and sensory conduction velocity (MCV and SCV) changes, compound muscle and sensory nerve action potential amplitudes (CMAP and SNAP), and F-wave occurrence (FO). Slower MCVs were found in three of five SMA I patients; all five exhibited markedly decreased CMAP amplitudes. Tibial nerve CMAP amplitudes significantly reduced in SMA II patients (p < 0.01). Slower SCVs and decreased SNAP amplitudes were observed in three of five SMA I patients but not in SMA II patients. Although FOs were reduced in both extremities of SMA I patients, the reduction was prominent in the tibial nerve of SMA II patients (p = 0.031). Loss of motor units may be widespread in the early stage of SMA I, while specific to the legs in young SMA II patients. SMA I showed sensory nerve degeneration, especially of large myelinated fibers. SMA II showed no sensory nerve abnormalities. (C) 2012 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 50 条
  • [41] Brain MRI abnormalities in a child with spinal muscular atrophy type II
    Luciana Losito
    Leonarda Gennaro
    Elisabetta Lucarelli
    Antonio Trabacca
    Acta Neurologica Belgica, 2021, 121 : 1883 - 1885
  • [42] NUSINERSEN IN ADULT SPINAL MUSCULAR ATROPHY PATIENTS
    Fadia, Mithila
    Shroff, Sheetal
    Simpson, Ericka
    MUSCLE & NERVE, 2019, 60 : S54 - S54
  • [43] What Time Is It? Circadian Rhythm Abnormalities in a Patient With Spinal Muscular Atrophy
    Gardner, Kelly
    Gipson, Kevin
    Epstein, Lawrence
    Bernard Kinane, T.
    Nelson, Benjamin A.
    PEDIATRIC PULMONOLOGY, 2025, 60 (03)
  • [44] Brain abnormalities in spinal muscular atrophy type 1 with neurodevelopmental disorders
    Holanda Mendonca, R.
    Diogenes Alencar Sindeaux, R.
    Gontijo Camelo, C.
    Barbante Casella, E.
    Faria Silva Chillon, K.
    Jose da Rocha, A.
    Zanoteli, E.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [45] Diagnostic Testing for Patients with Spinal Muscular Atrophy
    Brandsema, John F.
    Gross, Brianna N.
    Matesanz, Susan E.
    CLINICS IN LABORATORY MEDICINE, 2020, 40 (03) : 357 - +
  • [46] The Impact of Vulnerability on patients with Spinal Muscular Atrophy
    Grazia Cattinari, M.
    De Lemus, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 835 - 835
  • [47] Treatment strategies for patients with spinal muscular atrophy
    De Waele, Liesbeth
    Servais, Laurent
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024,
  • [48] Hip dislocation in patients with spinal muscular atrophy
    Sporer, SM
    Smith, BG
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2003, 23 (01) : 10 - 14
  • [49] Functional Abnormalities of Cerebellum and Motor Cortex in Spinal Muscular Atrophy Mice
    Tharaneetharan, Arumugarajah
    Cole, Madison
    Norman, Brandon
    Romero, Nayeli C.
    Wooltorton, Julian R. A.
    Harrington, Melissa A.
    Sun, Jianli
    NEUROSCIENCE, 2021, 452 : 78 - 97
  • [50] Mitochondrial Dysfunction and Morphological Abnormalities in Cellular Models of Spinal Muscular Atrophy
    Acsadi, G.
    Li, X.
    Brenner, C. A.
    Parker, G. C.
    Silver, R. B.
    ANNALS OF NEUROLOGY, 2009, 66 : S101 - S102